Effect of Delivery System of Photosensitizer in Photodynamic Therapy and Tumor
Jonathan R. Ballard
Abstract
Jonathan R. Ballard
Abstract
The effect of Photofrin photosensitizer encapsulated in liposomal delivery vehicles was studied by observing tumor response after conducting photodynamic therapy (PDT). PDT involves the administration of a tumor-localizing photosensitizing agent followed by activation of the agent by light of a specific wavelength. The therapy results in a sequence of photochemical and photobiological processes that cause irreversible damage to tumor tissue. Three liposomal delivery vehicles were chosen to deliver the photosensitizer in vivo: DDPC/cholesterol, DMPC/ HPC and stealth liposomes. Selective tumor destruction was observed with each delivery vehicle upon observation of tumor response.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The effect of Photofrin photosensitizer encapsulated in liposomal delivery vehicles was studied by observing tumor response after conducting photodynamic therapy (PDT). PDT involves the administration of a tumor-localizing photosensitizing agent followed by activation of the agent by light of a specific wavelength. The therapy results in a sequence of photochemical and photobiological processes that cause irreversible damage to tumor tissue. Three liposomal delivery vehicles were chosen to deliver the photosensitizer in vivo: DDPC/cholesterol, DMPC/ HPC and stealth liposomes. Selective tumor destruction was observed with each delivery vehicle upon observation of tumor response.
Key concepts: Photosensitizer, Photodynamic therapy, Medicine, Delivery system, Chemistry, Biomedical engineering, Photochemistry, Organic chemistry